SOLARIS (A021703): A national, multicenter, randomized, double-blind phase III trial of vitamin D supplementation in combination with standard chemotherapy plus bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC)
      Google Scholar   
Citation:
Annals of Oncology vol 35 (Supplement 2) S1219
Meeting Instance:
ESMO 2024
Year:
2024
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
Pharmavite LLC  
Grants:
U10CA180821, U10CA180882; R01CA205406, U10CA180820 (ECOG-ACRIN), U10CA180868 (NRG Oncology), U10CA180888 (SWOG);  
Corr. Author:
 
Authors:
                                 
Networks:
LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY016, NORTHWELL, PCRC   
Study
Alliance-A021703
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: